These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3915472)
41. Neurophysiological studies on workers exposed to lead. Triebig G Br J Ind Med; 1985 Jul; 42(7):503. PubMed ID: 4016000 [No Abstract] [Full Text] [Related]
42. Calculating blood lead concentrations: a perspective. Manton W J Toxicol Clin Toxicol; 1995; 33(4):389-90. PubMed ID: 7629913 [No Abstract] [Full Text] [Related]
43. Biomarkers in neurodevelopmental toxicology. Needleman HL Environ Health Perspect; 1987 Oct; 74():149-52. PubMed ID: 3691426 [No Abstract] [Full Text] [Related]
44. Lead as a public health problem: is it overestimated? Lave LB J Health Econ; 1989 Jun; 8(2):247-50. PubMed ID: 10296998 [No Abstract] [Full Text] [Related]
47. A note concerning the papers of Landrigan and associates. Gartside PS; Panke RK J Pediatr; 1977 Sep; 91(3):514-6. PubMed ID: 894437 [No Abstract] [Full Text] [Related]
48. [Research development of the influence of psychological stimulation acception and lead exposure during pregnancy on neural system of fetus and infant]. Gong X; Hao J; Tao F Wei Sheng Yan Jiu; 2011 Jan; 40(1):133-6. PubMed ID: 21434332 [TBL] [Abstract][Full Text] [Related]
49. [Cellular and molecular biological aspects in environmental toxicology]. Schlipköter HW; Abel J; Behrendt H; Dehnen W; Gleichmann E; Seemayer N; Wiegand H Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1986 Oct; 182(5-6):431-48. PubMed ID: 3101317 [TBL] [Abstract][Full Text] [Related]
50. Lead and the developing nervous system. De Gennaro LD Growth Dev Aging; 2002; 66(1):43-50. PubMed ID: 12212631 [TBL] [Abstract][Full Text] [Related]
51. Environmental factors associated with a spectrum of neurodevelopmental deficits. Mendola P; Selevan SG; Gutter S; Rice D Ment Retard Dev Disabil Res Rev; 2002; 8(3):188-97. PubMed ID: 12216063 [TBL] [Abstract][Full Text] [Related]
52. Subclinical effects of chronic increased lead absorption--a prospective study. III. Neurologic findings at follow-up examination. Spivey GH; Baloh RW; Brown CP; Browdy BL; Campion DS; Valentine JL; Morgan DE; Culver BD J Occup Med; 1980 Sep; 22(9):607-12. PubMed ID: 7452384 [TBL] [Abstract][Full Text] [Related]
53. The characteristics of an adverse effect: using the example of developing a standard for lead. Marcus WL; Cothern CR Drug Metab Rev; 1985-1986; 16(4):423-40. PubMed ID: 3915472 [No Abstract] [Full Text] [Related]